|
시장보고서
상품코드
2152445
뇌척수액 관리 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 밸브별, 유형별, 연령별, 지역별 및 부문별 전망(2026-2033년)Cerebral Spinal Fluid Management Market Size, Share & Trends Analysis Report By Product (CSF Shunts, By CSF Drainage), By Valve (Adjustable Valve Shunts), By Type, By Age, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
세계의 뇌척수액 관리 시장 규모는 2025년에 7억 2,420만 달러로 평가되며, 2026년 7억 6,1,900만 달러에서 2033년에는 11억 달러로 확대되어, 2026-2033년 연평균 성장률(CAGR) 5.4%로 성장할 것으로 예측됩니다.
뇌실 내에 존재하는 혈장의 한외여과액인 뇌척수액은 영양소 공급, 노폐물 제거, 그리고 뇌 보호에 있으며, 매우 중요한 역할을 하고 있습니다. 뇌강 내에 과도한 뇌척수액이 축적되면 수두증 등의 질환을 유발할 가능성이 있습니다. 시장 성장의 원동력은 전 세계에서 수두증 및 기타 뇌 관련 질환을 치료하기 위한 뇌척수액(CSF) 관리에 대한 수요가 증가하고 있기 때문입니다.
시장 성장은 주로 수두증이나 수막염과 같은 신경질환의 발생률 증가에 의해 주도되고 있으며, 이러한 질환에는 효과적인 뇌척수액(CSF) 관리 솔루션이 요구되고 있습니다. 또한 의료 기술의 발전으로 인해 보다 효율적이고 비침습적인 치료법의 개발이 가능해졌으며, 이는 시장 성장에 크게 기여하고 있습니다. 신경질환에 걸리기 쉬운 고령 인구의 증가 또한 시장 수요를 더욱 부추기고 있습니다.
또한 신경질환 유병률의 증가에 따라 의료기기 분야에서는 급속한 성장과 혁신이 진행되고 있습니다. 주요 기업이 첨단 기술을 탑재한 신제품을 출시하고 있으며, 이것이 시장 성장에 긍정적인 영향을 미칠 것으로 예상되므로, 이러한 동향은 업계에 큰 기회가 되고 있습니다.
또한 개발도상국에서의 기술 도입 가능성이 높기 때문에 뇌척수액(CSF) 관리 시장도 확대될 것으로 예상됩니다. 이는 CSF 관련 질환의 유병률 상승, 시장 진입 기업의 증가, 그리고 효과적인 CSF 관리 솔루션에 대한 수요 증가에 의해 주도되고 있습니다. 또한 신흥 경제국의 의료 산업은 의료 기술에 대한 정부 투자와 견고한 의료기기 산업의 확립에 힘입어 급속히 발전하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법 및 범위
제2장 요약
제3장 뇌척수액 관리 시장: 변수, 동향, 범위
- 시장 개요 및 향후 전망
- 시장 규모 및 성장 전망
- 시장 역학
- 뇌척수액 관리 시장 분석 툴
제4장 뇌척수액 관리 시장: 제품별 추정 및 동향 분석
- 뇌척수액 관리 시장: 제품별 동향 분석, 2025-2033년
- 뇌척수액 션트
- 뇌척수액 배액
제5장 뇌척수액 관리 시장: 밸브별 추정 및 동향 분석
- 뇌척수액 관리 시장: 밸브별 변동 분석, 2025년 및 2033년
- 조절 가능 밸브 션트
- 단일 압력 밸브 션트
제6장 뇌척수액 관리 시장: 유형별 추정 및 동향 분석
- 뇌척수액 관리 시장: 유형별 동향 분석, 2025-2033년
- 뇌실-복강 션트(VP 션트)
- 뇌실-심방 션트(VA 션트)
- 요추-복강 션트(LP 션트)
- 뇌실-흉강 션트(VPL)
제7장 뇌척수액 관리 시장: 연령대별 추정 및 동향 분석
- 뇌척수액 관리 시장: 연령대별 동향 분석, 2025-2033년
- 성인
- 소아
제8장 뇌척수액 관리 시장: 지역별 추정 및 동향 분석
- 뇌척수액 관리 시장 지역별 점유율, 2025-2033년
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 태국
- 라틴아메리카
- 브라질
- 아르헨티나
- 중동 및 아프리카
- 사우디아라비아
- UAE
- 남아프리카
- 쿠웨이트
제9장 경쟁 현황
- 주요 시장 진입 기업의 최근 동향 및 영향 분석
- 기업 분류
- 기업 히트맵 분석
- 기업 개요
- B. Braun Melsungen AG
- Integra LifeSciences Corporation
- Spiegelberg GmbH & Co. KG
- Medtronic
- Sophysa
- Beckersmith Medical, Inc
- Natus Medical Inc.
- Elekta AB
- Phoenix Biomedical Corp.
The global cerebral spinal fluid management market size was valued at USD 724.2 million in 2025 and is projected to grow from USD 761.9 million in 2026 to USD 1,100 million in 2033, at a CAGR of 5.4% from 2026 to 2033. Cerebrospinal fluid, an ultrafiltrate of plasma found in the brain's ventricles, plays crucial roles in supplying nutrients, removing waste, and protecting the brain. Accumulation of excessive cerebrospinal fluid in the brain's cavities can lead to conditions such as hydrocephalus. Market growth is driven by the rising need for cerebrospinal fluid (CSF) management to treat Hydrocephalus and other brain-related disorders worldwide.
Market growth is primarily driven by the rising incidence of neurological disorders, such as hydrocephalus and meningitis, which require effective cerebrospinal fluid (CSF) management solutions. In addition, advancements in medical technology have significantly contributed to this growth by enabling the development of more efficient, less invasive treatment methods. The rising geriatric population, which is more vulnerable to neurological conditions, further boosts market demand.
Moreover, the medical device sector is experiencing rapid growth and innovation due to the increasing prevalence of neurological diseases. This trend presents significant opportunities for the industry, as key players are introducing new products featuring advanced technology, which is expected to positively impact market growth.
The CSF management market is also anticipated to expand due to the high potential for technology adoption in developing countries. This is driven by the rising prevalence of CSF-related disorders, the increasing number of market participants, and the growing demand for effective CSF management solutions. Furthermore, the healthcare industry in emerging economies is rapidly developing, supported by government investments in medical technology and the establishment of robust medical device industries.
Global Cerebral Spinal Fluid Management Market Report Segmentation
This report forecasts revenue growth at product, age group, and country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the cerebral spinal fluid management market report based on product, valve, type, age group, and region.
- Product Outlook (Revenue, USD Million, 2021 - 2033)
CSF Shunts
CSF Drainage
- Valve Outlook (Revenue, USD Million, 2021 - 2033)
Adjustable Valve Shunts
Mono-pressure Valve Shunts
- Type Outlook (Revenue, USD Million, 2021 - 2033)
Ventriculoperitoneal (VP) Shunts
Ventriculoatrial (VA) Shunts
Lumboperitoneal (LP) Shunts
Ventriculopleural (VPL) Shunts
- Age Group Outlook (Revenue, USD Million, 2021 - 2033)
Adult
Pediatric
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Cerebral Spinal Fluid Management Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Billion)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Cerebral Spinal Fluid Management Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter's Analysis
Chapter 4. Cerebral Spinal Fluid Management Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Cerebral Spinal Fluid Management Market: Product Movement Analysis, USD Million, 2025 & 2033
- 4.3. CSF Shunts
- 4.3.1. CSF Shunts Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4. CSF Drainage
- 4.4.1. CSF Drainage Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Cerebral Spinal Fluid Management Market: Valve Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Cerebral Spinal Fluid Management Market: Valve Movement Analysis, USD Million, 2025 & 2033
- 5.3. Adjustable Valve Shunts
- 5.3.1. Adjustable Valve Shunts Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4. Mono-pressure Valve Shunts
- 5.4.1. Mono-pressure Valve Shunts Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Cerebral Spinal Fluid Management Market: Type Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Cerebral Spinal Fluid Management Market: Type Movement Analysis, USD Million, 2025 & 2033
- 6.3. Ventriculoperitoneal (VP) Shunts
- 6.3.1. Ventriculoperitoneal (VP) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4. Ventriculoatrial (VA) Shunts
- 6.4.1. Ventriculoatrial (VA) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Lumboperitoneal (LP) Shunts
- 6.5.1. Lumboperitoneal (LP) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Ventriculopleural (VPL) Shunts
- 6.6.1. Ventriculopleural (VPL) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Cerebral Spinal Fluid Management Market: Age Group Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Cerebral Spinal Fluid Management Market: Age Group Movement Analysis, USD Million, 2025 & 2033
- 7.3. Adult
- 7.3.1. Adult Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4. Pediatric
- 7.4.1. Pediatric Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Cerebral Spinal Fluid Management Market: Regional Estimates & Trend Analysis
- 8.1. Cerebral Spinal Fluid Management Market Share, By Region, 2025 & 2033, USD Million
- 8.2. North America
- 8.2.1. North America Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.2.2. U.S.
- 8.2.2.1. U.S. Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.2.3. Canada
- 8.2.3.1. Canada Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.2.4. Mexico
- 8.2.4.1. Mexico Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.2. UK
- 8.3.2.1. UK Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Germany
- 8.3.3.1. Germany Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.4. France
- 8.3.4.1. France Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.5. Italy
- 8.3.5.1. Italy Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.6. Spain
- 8.3.6.1. Spain Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.7. Denmark
- 8.3.7.1. Denmark Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.8. Sweden
- 8.3.8.1. Sweden Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.9. Norway
- 8.3.9.1. Norway Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.2. China
- 8.4.2.1. China Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.3. Japan
- 8.4.3.1. Japan Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.4. India
- 8.4.4.1. India Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.5. South Korea
- 8.4.5.1. South Korea Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.6. Australia
- 8.4.6.1. Australia Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.7. Thailand
- 8.4.7.1. Thailand Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.2. Brazil
- 8.5.2.1. Brazil Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.3. Argentina
- 8.5.3.1. Argentina Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.2. Saudi Arabia
- 8.6.2.1. Saudi Arabia Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.3. UAE
- 8.6.3.1. UAE Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.4. South Africa
- 8.6.4.1. South Africa Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.5. Kuwait
- 8.6.5.1. Kuwait Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis by Key Market Participants
- 9.2. Company Categorization
- 9.3. Company Heat Map Analysis
- 9.4. Company Profiles
- 9.4.1. B. Braun Melsungen AG
- 9.4.1.1. Participant's Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. Integra LifeSciences Corporation
- 9.4.2.1. Participant's Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. Spiegelberg GmbH & Co. KG
- 9.4.3.1. Participant's Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. Medtronic
- 9.4.4.1. Participant's Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. Sophysa
- 9.4.5.1. Participant's Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. Beckersmith Medical, Inc
- 9.4.6.1. Participant's Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. Natus Medical Inc.
- 9.4.7.1. Participant's Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. Elekta AB
- 9.4.8.1. Participant's Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. Phoenix Biomedical Corp.
- 9.4.9.1. Participant's Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.1. B. Braun Melsungen AG
